Why design for manufacture matters more as medical devices get more complex

As medical devices grow more sophisticated, integrating advanced optics, electronics, software, and complex mechanical systems, the path from concept to production becomes increasingly complex. Innovation teams often find that progress appears smooth through early development, only to stall as programs approach manufacturing readiness. This is where Design for Manufacture (DfM) and Design for Assembly (DfA) become critical. Not as a late‑stage checklist, but as a strategic mindset embedded from the earliest design decisions.

In this article, I share why manufacturability so often becomes the limiting factor in complex medical device programs, and how early DfM thinking can protect design intent, reduce risk, and keep innovation moving forward.

Why programs lose momentum as they near manufacture

In many medical device programs, loss of momentum can often be traced back to a small number of technically ambitious design features.

These might include:

A challenging molded detail
A precision alignment requirement
A delicate assembly process that must eventually scale

These features are not introduced casually. They exist because, if feasible, they deliver meaningful functional or user benefits, often in a high-pressure clinical environment.

The risk is not in pursuing them, but in failing to address their manufacturability early.

Because these features are often central to device performance, the broader system architecture tends to build around them. When manufacturability discussions are deferred, teams may discover late in development that a core assumption does not hold.

At that stage, the cost is no longer localized. A single unresolved manufacturing risk can cascade into widespread redesign, re-testing, and delay.

This is why teams often experience the frustrating adage that: The last 20% of the work takes 80% of the time.

How complexity multiplies risk

As clinical, technical, and system complexity increases, the challenge is not that teams face new types of risks, but that they face many more of them, and simultaneously – often disproportionately so. Each additional component, interface, tolerance stack‑up, and assembly step introduces its own potential failure modes.

Managing this effectively requires diligence early in the program. Teams need to be systematic about identifying, prioritizing, and mitigating risks while design freedom is still high. When complexity grows without a parallel increase in rigor, the likelihood of late‑stage surprises increase dramatically.

Why manufacturability becomes mission‑critical at scale

Manufacturability challenges that feel minor at prototype stage can quickly become serious bottlenecks as programs scale into design transfer and medical device manufacturing.

For example:

A small assembly issue that is acceptable at clinical trial volumes can reduce throughput at commercial scale
Tolerances that work for one-off builds may become unrealistic across thousands of units

As programs transition from early builds into validated production, there is far less flexibility to absorb these issues.

This is why manufacturability becomes more, not less, important as devices move closer to market.

What Design for Manufacture really means in medical devices

In a medical device context, Design for Manufacture extends far beyond traditional manufacturing efficiency. It is tightly coupled to patient safety, regulatory compliance, quality, and long-term reliability.

Design for Manufacture spans many considerations across a program. One of these areas is Design for Assembly and below are a few common examples where where this shows up in practice, particularly in complex medical devices.

Designing for assembly and testing

Good design for manufacture asks more nuanced questions than simply “can this be built?”

It considers whether assemblies can be tested in stages, so a low-cost subassembly failure does not result in scrapping a fully built device.

Preventing assembly errors

DfM also examines whether parts can be installed incorrectly, and how the design can actively prevent that. Physical mistake‑proofing features, often referred to as poka‑yoke, guide correct assembly without relying solely on instructions or training.

Designing for assembly confirmation

Sometimes, design for manufacture means adding features that exist solely to support assembly confirmation. A small viewport, for example, might allow a technician to visually confirm insertion depth or alignment during assembly, helping catch issues early and prevent downstream failures. These types of decisions rarely show up in outward aesthetics, but they play a significant role in product robustness and manufacturing quality.

DfM, usability, and regulatory readiness are interconnected

Manufacturability does not exist in isolation. When Design for Manufacture considerations are introduced late, teams may be forced to revisit designs after formative usability evaluations, system characterization, or early integration testing have already taken place. Even small changes at that stage can have outsized downstream effects, increase cost and extend timelines.

Early DfM helps prevent this by aligning usability, design intent, and production reality from the outset. When early testing reflects realistic manufacturing constraints and assembly methods, teams reduce late‑stage rework and establish a clearer, more traceable path toward regulatory submission. The result is a smoother transition into formal verification and validation, with greater confidence that the product being evaluated truly represents what will be manufactured and released.

How early Design for Manufacture protects design intent

When manufacturability thinking is integrated early, it becomes part of the creative process rather than a constraint imposed later. Designers and engineers have greater freedom to explore solutions that balance performance, usability, and production realities.

In contrast, when manufacturability is addressed late, changes tend to be shoehorned into an already-locked design, increasing the risk of negative impact to form, function, or user experience.

When design, engineering, and manufacturing are aligned from the start, the results are tangible. Parts look the way designers intended, engineers can focus on functional performance, and the production floor is not fighting the product. In short: a faster route to viable commercial launch.

4 men at a table with prototype drawings on a table

Real‑world lessons from complex devices

Early Design for Manufacture thinking consistently pays dividends in real programs, particularly as systems grow more complex and move toward scale. Here are three examples:

1. Designing for real-world assembly constraints

In the development of Canfield Scientific’s Vectra WB 360 3D whole body imaging system, Ensera Design recognized early that maintaining tight positional tolerances across a large, welded frame would be unrealistic once the system was shipped and assembled on-site.

Rather than forcing demanding tolerances into the frame itself, our team designed a micro-adjustable camera pod mount paired with a tool-less access hatch. This allowed technicians to fine-tune alignment during installation, accommodating real-world variation without compromising performance.

Learn more about the Vectra WB 360 case study.

Canfield Scientific Vectra WB 360 whole-body imaging

2. Designing for manufacturability in wearable neurotechnology

The Neupulse device introduced a different set of DfM challenges. As a wrist‑worn neurostimulation system, it needed to integrate electronics, electrodes, and a wearable form factor in a way that balanced comfort, discretion, and functional performance while remaining realistic to assemble and scale.

Early DfM thinking helped ensure that critical elements such as housing design, electrode positioning, and assembly interfaces could be produced consistently and assembled reliably. By addressing manufacturability in parallel with usability, ergonomics, and system integration, the team avoided late‑stage redesigns that could have disrupted clinical momentum or delayed scale‑up. The resulting architecture supported repeatable assembly and production‑intent decision‑making without compromising the user experience.

Learn more about the Neupulse case study.

Neurotherapeutics Neupulse device shown on wrist

3. Designing for modularity and scalability

In another program, Ensera Design worked with a surgical device client whose product needed to interface with a range of third-party endoscopes. Rather than redesigning the entire assembly for each variation, the team applied early DfM thinking to create a modular architecture made up of four components. Only the lower interface component needed to change to accommodate different endoscope models, while the remaining components and the overall assembly process stayed the same.

This approach helped to:

Simplify assembly line validation by keeping the process consistent across SKUs
Enable better volume pricing through shared components
Reduce inventory complexity by limiting the number of unique parts

By designing for modularity and repeatability from the outset, the team avoided unnecessary duplication and made the transition to production significantly more efficient.

A closing perspective on unlocking progress through DfM

For teams starting complex medical device programs, the most valuable advice is simple. Identify the manufacturing challenges you expect to be hardest and start discussing them early with suppliers. Working with partners who have broad supplier networks opens options, and one supplier’s limitation does not define what is possible.

When manufacturability is not considered early, the warning signs are familiar. Programs encounter vendor no‑quotes, higher‑than‑expected part pricing, forced redesigns, and repeated testing of elements assumed to be locked. These issues increase cost, extend timelines, and drive avoidable compromises at the point when flexibility is lowest.

Nearly every design decision carries manufacturing trade‑offs. The value of early DfM is understanding those technical, financial, and schedule implications while there is still freedom to act.

Far from constraining innovation, early manufacturability thinking enables it. Progress toward a device that cannot be made is not real progress. When DfM is embedded from the outset, teams preserve creativity, reduce risk, and greatly increase the likelihood of successful, scalable outcomes.

How Ensera Design can help

If you’re developing a new medical device and starting to think about the realities of scaling to manufacture, early Design for Manufacture considerations can make the difference between steady progress and painful late‑stage rework. At Ensera Design, we partner with teams from the earliest concept phases to identify manufacturing risks, challenge assumptions, and design architectures that balance performance, usability, and scalability.

Speak to our team to identify risks early and design products that are ready for scalable, real-world production.

Get in touch with our team